AU8997498A - Tryptase inhibitor - Google Patents

Tryptase inhibitor

Info

Publication number
AU8997498A
AU8997498A AU89974/98A AU8997498A AU8997498A AU 8997498 A AU8997498 A AU 8997498A AU 89974/98 A AU89974/98 A AU 89974/98A AU 8997498 A AU8997498 A AU 8997498A AU 8997498 A AU8997498 A AU 8997498A
Authority
AU
Australia
Prior art keywords
tryptase inhibitor
tryptase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89974/98A
Inventor
Takashi Imagawa
Shigeki Kuwahara
Koji Naito
Youichiro Naito
Shinichiro Ono
Hiroshi Sakashita
Masahiro Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU8997498A publication Critical patent/AU8997498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU89974/98A 1997-09-05 1998-09-04 Tryptase inhibitor Abandoned AU8997498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24138797 1997-09-05
JP9-241387 1997-09-05
PCT/JP1998/003978 WO1999012918A1 (en) 1997-09-05 1998-09-04 Tryptase inhibitor

Publications (1)

Publication Number Publication Date
AU8997498A true AU8997498A (en) 1999-03-29

Family

ID=17073538

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89974/98A Abandoned AU8997498A (en) 1997-09-05 1998-09-04 Tryptase inhibitor

Country Status (2)

Country Link
AU (1) AU8997498A (en)
WO (1) WO1999012918A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221914B1 (en) 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
JP2003509417A (en) 1999-09-14 2003-03-11 アルタナ ファルマ アクチエンゲゼルシャフト Tryptase inhibitor
TR200402164T4 (en) 1999-12-20 2004-10-21 Altana Pharma Ag Tryptase inhibitors
CA2438594A1 (en) 2001-01-31 2002-08-08 Altana Pharma Ag Diazocine derivatives and their use as tryptase inhibitors
CA2438685A1 (en) 2001-02-21 2002-08-29 Altana Pharma Ag Tryptase inhibitors
WO2002066420A2 (en) 2001-02-21 2002-08-29 Altana Pharma Ag Tryptase inhibitors
ATE348803T1 (en) 2001-06-19 2007-01-15 Altana Pharma Ag TRYPTASE INHIBITORS
US6884889B2 (en) 2002-03-25 2005-04-26 Bristol-Myers Squibb Co. Processes for the preparation of antiviral 7-azaindole derivatives
CA2497829A1 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Method to treat allergic rhinitis
CN102746295B (en) * 2012-06-20 2014-10-15 上海阿达玛斯试剂有限公司 Preparation method for 4-substituted-7-azaindole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10501238A (en) * 1994-06-01 1998-02-03 アリス ファーマシューティカル コーポレイション Compositions and methods for treating mast cell mediated conditions
EP0782571A1 (en) * 1994-09-23 1997-07-09 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell inflammatory condition

Also Published As

Publication number Publication date
WO1999012918A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU7139598A (en) Protease inhibitors
AU5272198A (en) EMP-charge-eliminator
AU2723099A (en) Tryptase inhibitors
AU8997498A (en) Tryptase inhibitor
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU6185898A (en) Clavaspirins
AU9300298A (en) Protease inhibitors
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU7252398A (en) Protease inhibitors
AU5391798A (en) Thiamacrolides
AU9183798A (en) Catamaran - bicycle - kayak
AU8991998A (en) Renovative pipeliner
AU4469997A (en) Heregulin-gamma
AU5540298A (en) Rockbolts
AU7780498A (en) Cafetiere
AU6507298A (en) Renovative pipeliner
AU6237398A (en) N-het-substituted glycerophosphoethanolamines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase